EUBREAST 20 (R) / NAC-AX Delphi Consensus Study

Together with the Breast Research Collaborative

20 June 2025 – This study will close very soon but there is still the opportunity to participate and to help shape international guidelines on axillary management (SLNB, MLNB, TAD) for node-positive breast cancer patients undergoing neoadjuvant chemotherapy.

Authors

Mr. James Lucocq, Mr. Lachlan Dick, Dr. Andreas Karakatsanis, Dr. Susie X. Sun, Dr. Jennifer
Tseng, Professor Judy Boughey, Professor Oreste Gentilini, Professor Thorsten Kühn,
Professor Michael Dixon, Professor John Benson, Professor Cliona Kirwan, Mr. Kenneth Elder

Protocol

NAC-AX Delphi Study

Inclusion criteria

*Panellists must be a consultant or attending breast oncology surgeon actively practicing in their respective healthcare system

*Panellists must be proficient in English to ensure clear understanding of the Delphi questions and responses

*Panellists should have a willingness to participate in multiple Delphi rounds (up to three rounds) and respond within the specified timelines

*Panellists must be from a OECD country in order to permit the possibility of consensus 

Collaborators

The following societies have also offered their endorsement:
🇬🇧 Association of Breast Surgery (ABS)
🇺🇸 American Society of Breast Surgeons (ASBrS)
🇦🇺 🇳🇿 BreastSurgANZ
🇪🇺 European Society of Surgical Oncology (ESSO)
🌎 Breast Surgery International (BSI)

Link to study

📩 Round 1 is live: https://lnkd.in/dahn-MPi

Flyer